S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Low VIX? 3 High Beta Stocks To Boost Your Returns
Best Bear Market Funds: Top 3 Investment Options to Consider
How and When to Roll Your Options Positions?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Low VIX? 3 High Beta Stocks To Boost Your Returns
Best Bear Market Funds: Top 3 Investment Options to Consider
How and When to Roll Your Options Positions?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Low VIX? 3 High Beta Stocks To Boost Your Returns
Best Bear Market Funds: Top 3 Investment Options to Consider
How and When to Roll Your Options Positions?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
Low VIX? 3 High Beta Stocks To Boost Your Returns
Best Bear Market Funds: Top 3 Investment Options to Consider
How and When to Roll Your Options Positions?
NASDAQ:GRPH

Graphite Bio (GRPH) Stock Price, News & Analysis

$3.18
-0.09 (-2.75%)
(As of 03/21/2024)
Today's Range
$3.05
$3.23
50-Day Range
$3.18
$26.11
52-Week Range
$2.01
$4.26
Volume
328,300 shs
Average Volume
282,405 shs
Market Capitalization
$185.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GRPH stock logo

About Graphite Bio Stock (NASDAQ:GRPH)

Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. The company offers GPH102 for the treatment of beta-thalassemia; and GPH201 for the treatment of XSCID, a life-threatening disease for multiple mutations in a single gene. It also offers GPH301, a product candidate for the treatment of Gaucher disease, a genetic disorder that results in a deficiency in the glucocerebrosidase enzyme. The company was formerly known as Integral Medicines, Inc., and changed its name to Graphite Bio, Inc. in August 2020. Graphite Bio, Inc. was incorporated in 2017 and is based in South San Francisco, California.

GRPH Stock Price History

GRPH Stock News Headlines

GRPH Mar 2024 5.000 put
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
VERI, STI and VERB among mid-day movers
GRPH Mar 2024 7.500 call
Graphite Bio, Inc. (GRPH)
The Small Biotech with a BIG Cancer Solution
There's a new cancer treatment so precise, it's been called a "smart bomb." One that can deliver a toxic payload directly to tumors while bypassing healthy cells.
What Makes Graphite Bio, Inc. (GRPH) a New Buy Stock
Graphite Bio To Merge With LENZ Therapeutics; Stock Down In Pre-market
Graphite Bio Inc GRPH
See More Headlines
Receive GRPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Graphite Bio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/20/2023
Ex-Dividend for 3/21 Dividend
3/15/2024
Dividend Payable
3/21/2024
Today
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:GRPH
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Net Income
$-124,650,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$3.15 per share

Miscellaneous

Free Float
35,874,000
Market Cap
$185.20 million
Optionable
Not Optionable
Beta
0.20
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

GRPH Stock Analysis - Frequently Asked Questions

How have GRPH shares performed in 2024?

Graphite Bio's stock was trading at $18.34 at the beginning of the year. Since then, GRPH stock has decreased by 82.7% and is now trading at $3.18.
View the best growth stocks for 2024 here
.

How were Graphite Bio's earnings last quarter?

Graphite Bio, Inc. (NASDAQ:GRPH) announced its quarterly earnings results on Monday, March, 20th. The company reported ($3.08) EPS for the quarter, topping analysts' consensus estimates of ($3.43) by $0.35.

How often does Graphite Bio pay dividends? What is the dividend yield for Graphite Bio?

Graphite Bio declared a dividend on Friday, March 15th. Stockholders of record on Monday, March 18th will be paid a dividend of $7.21 per share on Thursday, March 21st. This represents a yield of 28.93%. The ex-dividend date is Friday, March 15th.
Read our dividend analysis for GRPH
.

When did Graphite Bio's stock split?

Shares of Graphite Bio reverse split on Friday, March 22nd 2024. The 1-7 reverse split was announced on Friday, March 22nd 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, March 22nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

When did Graphite Bio IPO?

Graphite Bio (GRPH) raised $224 million in an IPO on Friday, June 25th 2021. The company issued 14,000,000 shares at $15.00-$17.00 per share.

Who are Graphite Bio's major shareholders?

Graphite Bio's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (2.46%), Vanguard Group Inc. (2.45%), Nantahala Capital Management LLC (1.42%), BML Capital Management LLC (0.77%), BML Capital Management LLC (0.77%) and Sectoral Asset Management Inc. (0.76%). Insiders that own company stock include Biocapital LP Samsara and Phil Gutry.
View institutional ownership trends
.

How do I buy shares of Graphite Bio?

Shares of GRPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GRPH) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners